Correvio might look for buyer after FDA panel shoots down heart drug

Correvio Pharma Corp could hunt for a potential buyer now that its pivotal heart drug is not likely to win FDA approval.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news